Physician profile
Ting Zhang
NPI 1356769608
$35,593.96
in general payments reported to CMS, 2019-2025
13 companies · $3,794 in 2025
The $3,794 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,820 · 2021: $756 · 2022: $20K · 2023: $2,557 · 2024: $5,728 · 2025: $3,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,502 · Food and Beverage: $3,514 · Education: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,502.03 |
| Food and Beverage | $3,514.46 |
| Education | $1,062.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,662.07 | 2020-2024 | |
| Smith+Nephew, INC. | $3,645.53 | 2022-2023 | Firstpass, Fast-Fix, Novostitch |
| Trimed, INC. | $3,249.53 | 2024 | |
| Zimmer Biomet Holdings, INC. | $2,404.79 | 2022-2025 | Comprehensive Shoulder System |
| Stryker Corporation | $2,300.23 | 2024-2025 | Mako, Triathlon |
| Great Lakes Orthopedics | $1,387.56 | 2020 | |
| Axogen | $869.78 | 2025 | |
| Conformis, INC. | $736.36 | 2021 | |
| Steelhead Surgical INC | $226.87 | 2024 | |
| Depuy Synthes Sales INC. | $32.37 | 2024 | |
| Encore Medical, LP | $31.61 | 2022 | |
| Tactile Systems Technology INC | $28.00 | 2025 | Flexitouch Plus, Nimbl |
| Medical Device Business Services, INC. | $19.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ting Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.